tmmonline.nz  |   landlords.co.nz        About Good Returns  |  Advertise  |  Contact Us  |  Terms & Conditions  |  RSS Feeds

NZ's Financial Adviser News Centre

GR Logo
Last Article Uploaded: Saturday, December 28th, 10:36AM

Insurance

rss
Latest Headlines

Sovereign's medical changes welcomed

Sovereign’s changes to its legacy medical insurance products breaks ground. Strategy Financial director Graeme Lindsay says.

Friday, December 16th 2016, 7:43AM 3 Comments

by Graeme Lindsay

Graeme Lindsay

Sovereign has announced some changes to its Private Health medical product.  Included are:

  • A change in the Surgical Hospitalisation benefit from $300,000 per person per annum to unlimited.  Whilst this looks to be a big change, in practice, it is unlikely to apply to many policyholders.  For those poor souls who do get to $300,000 in a year, the change will be welcome.  It would be interesting to learn from Sovereign, (and the other insurers), how many policyholders ever exceed the old $300,000 limit in a year.
  • Up to $5,000 to cover breast symmetry surgery following a mastectomy.
  • Outpatient physio and medications covered under the unlimited surgical benefit for 6 months after surgery (3 months for Majorcare 2003).
  • Dental Support before certain chemotherapy and radiotherapy treatments.
  • Some treatments covered worldwide.
  • Increased Minor surgery cover.
  • Increased Home Nursing benefit after surgery.
  • These changes are all good for policyholders, but are hardly major.

The major change however, and one for which Sovereign is to be applauded, is the extending of cover for chemotherapy treatments approved by Medsafe but not funded by Pharmac, to its legacy products Absolute Health and Majorcare 2003.  (Note, that Majorcare issued prior to November 2003 didn’t exclude non-Pharmac treatments.)

It is impressive too, that the level of cover for these treatments is realistic rather than the token level ($10,000) introduced by Southern Cross recently.

Sovereign is also to be recognised for the fact that whilst their policy wording allows them to retrospectively change the terms of their medical products, they have never done so to restrict or remove a cover in place.  This change is a positive change for existing policyholders.
 

Graeme Lindsay runs Strategy Financial which provides research to advisers on insurance products. The comments in "Strategy Thoughts" outlines his view on recent product and policy changes.

Tags: health insurance Sovereign

« Kiwi company attracts $200 million global investmentFidelity's new boss rings in the changes »

Special Offers

Comments from our readers

On 15 December 2016 at 2:53 pm Donald said:
I agree with Graeme that the retrospective change to Majorcare and Absolute Health can be welcomed. However it still only covers Chemotherapy treatments so still doesn't compare well to the top rated major medical providers.I do challenge the change of terms etc notation where stated "they have never done so to restrict or remove cover in place". I recall only too well when Sovereign reduced within Majorcare the 6 month pre and post surgery specialist cover to 3 months; so so much for NEVER. Fortunately they recognized their misjudgement and reinstated the 6 month term after adviser reaction. I'll take guaranteed wording anytime for the benefit of my clients.
On 15 December 2016 at 5:09 pm Chatterbox said:
Graeme must have amnesia or not seen the evidence of retrospective changes made to policy terms, or, the evidence which has been gathered was undertaken with new versions in a concealed manner while retaining the same product and branding names and labels. Which by the way you are well aware of. Support for that practice from a person who generates income from the industry is bias and full of conflicts.
On 16 December 2016 at 11:23 am Tash said:
Good to see Sovereign catching up in some areas to the likes of Partners Life and AIA but as usual the devil is in the detail!
Interesting to note that the unlimited surgical benefit does not seem to apply to Cancer surgery and treatments (limited to $300,000).
Also interesting that treatments covered world wide, other than Australia, are limited to 75% of the NZ reasonable charge so the unlimited surgery benefit won't apply.
Unfortunate that the new dental support before some chemotherapy is only $1,500 and the breast symmetry treatment only $5,000.

Sign In to add your comment

 

print

Printable version  

print

Email to a friend
Insurance Briefs

Partners exits Adviser Support Programme
Partners Life has moved its Adviser Support Programme to a third party compliance provider.

Apex Advice buys life business
Auckland-based Apex Advice has acquired a well-established insurance advice business.

Chubb's latest champion
Young maths prodigy takes out actuarial award.

New book: Unlocking group insurance
Christchurch adviser Corey Williams has released a new book helping advisers and employers put group insurance schemes in place.

News Bites
Latest Comments
  • The good guys get told off
    “Very prudent points as always @JohnMilner. Whilst I don’t disagree with the process, I question any advantages from the...”
    4 days ago by Pragmatic
  • [The Wrap] The year that was - and what may happen next year
    “Hope you have a good recovery Phil. Interesting points 1.Box ticking already happening with SOA 's that look identical...”
    5 days ago by Very Frustrated Adviser
  • [The Wrap] The year that was - and what may happen next year
    “Nice summary Phil. In short: . Consumers will expect more from the industry for less . Advisers will be increasingly time...”
    5 days ago by Pragmatic
  • The good guys get told off
    “I can't quite reconcile the rationale, or lack thereof, with the comments so far. Pathfinder were found to have made misleading...”
    8 days ago by John Milner
  • The good guys get told off
    “As a follow on to this conversation: I'm assuming that the Regulator will be consistent by 'naming and shaming' the other...”
    8 days ago by Pragmatic
Subscribe Now

Cover Notes - Specific news aimed at risk advisers

Previous News
Most Commented On
About Us  |  Advertise  |  Contact Us  |  Terms & Conditions  |  Privacy Policy  |  RSS Feeds  |  Letters  |  Archive  |  Toolbox  |  Disclaimer
 
Site by Web Developer and eyelovedesign.com
x